Cardiac Vein Accessibility According to Heart Diseases and Sex: Implications for Cardiac Resynchronization Therapy

Jae-Sun Uhm1, Je Wook Park1, Hancheol Lee1

  • 1Department of Cardiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Insights

Cardiac vein accessibility for cardiac resynchronization therapy (CRT) is higher in heart failure (HF) patients, particularly those with nonischemic HF and females. This finding aids in optimizing CRT implantation success rates.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Imaging

Background:

  • Cardiac resynchronization therapy (CRT) is a key treatment for heart failure (HF) and dyssynchrony.
  • Cardiac vein accessibility is crucial for successful CRT lead placement.

Purpose of the Study:

  • To identify clinical factors influencing cardiac vein accessibility for CRT.
  • To compare vein accessibility in different HF subgroups and between sexes.

Main Methods:

  • Cardiac venography was performed in 255 patients undergoing CRT or electrophysiological study.
  • Vein diameters and branching angles were measured; easy accessibility defined as diameter ≥1.6 mm and angle ≥90°.
  • Baseline characteristics were compared between patients with and without easily accessible cardiac veins.

Main Results:

  • Cardiac veins were easily accessible in 74.1% of patients.
  • Accessibility was significantly higher in HF patients (89.3%) versus non-HF patients (67.8%).
  • Nonischemic HF (96.4%) and female patients (79.8%) showed greater accessibility compared to ischemic HF (68.4%) and male patients (68.3%).

Conclusions:

  • Cardiac vein accessibility for CRT is generally high but varies with HF type and sex.
  • Nonischemic HF and female sex are associated with improved cardiac vein accessibility.
  • Understanding these factors can help anticipate and manage potential challenges in CRT procedures.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
616
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
743
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.4K